Abbreviations: ANF, atrial natriuretic factor; ARP-WASP, actin-related protein-Wiskott-Aldrich syndrome protein; CAG, Synthetic promoter constructed from the cytomegalovirus (CMV) early enhancer element, chicken beta-actin promoter and the splice acceptor of the rabbit beta-globin set enrichment analysis; HEK293, human embryonic kidney 293 cells; HW/BW, heart weight/body weight; LoxP, locus of X-over P1 which is a binding site of Cre recombinase; LV, left ventricle; MADS, MCM1-AGAMOUS-DEFICIENS-SRF; MCK, muscle creatine kinase; Mer, mutated estrogen receptor; MHC, myosin heavy chain; MHz, Megahertz; Myl, myosin light chain; NADPH, nicotinamide adenine dinucleotide phosphate hydrogen; NOX, nicotinamide adenine dinucleotide phosphate oxidase; NT, untreated cells; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate buffer solution; PCR, polymerase chain reaction; PI3K/AKT, phosphatidylinositol-3-kinase and protein kinase B; PolyA, polyadenylation signal; PS, penicillin-streptomycin; RT-qPCR, real-time quantitative polymerase chain reaction; LVFWd, left ventricle free wall diastolic; LVFWs, left ventricle free wall systolic; ROS, reactive oxygen species; RV, right ventricle; Sa, systolic velocity at mitral annulus; SDS, sodium dodecyl sulfate; Sf, SRF-floxed locus; SOD2, superoxide dismutase 2; Spw, systolic velocity posterior wall; SRF, serum response factor; SRF HKO /CA, SRF heart-specific knock-out and -cardiac actin transgen overexpression; STARS, STriated muscle activator of rho signaling/actin-binding rho activating protein; SYBR, an asymmetrical cyanine dye binding to DNA; TGCRE, transgenic mouse expressing-MHC-MerCreMer; TGCA, transgenic mouse expressing-Cardiac Actin; Tg-r-ACTC1, transgenic mouse expressing rat -cardiac actin (ACTC1); UTC, urea-thiourea-chap buffer; Vcfc, shortening of velocity of circumferential fibers corrected for heart rate; VDAC, voltage-dependent anion channel.
AbstractThe expression of α-cardiac actin, a major constituent of the cytoskeleton of cardiomyocytes, is dramatically decreased in a mouse model of dilated cardiomyopathy triggered by inducible cardiac-specific serum response factor (Srf) gene disruption that could mimic some forms of human dilated cardiomyopathy. To investigate the consequences of the maintenance of α-cardiac actin expression in this model, we developed a new transgenic mouse based on Cre/LoxP strategy, allowing together the induction of SRF loss and a compensatory expression of α-cardiac actin. Here, we report that maintenance of α-cardiac actin within cardiomyocytes temporally preserved cytoarchitecture from adverse cardiac remodeling through a positive impact on both structural and transcriptional levels. These protective effects were accompanied in vivo by the decrease of ROS generation and protein carbonylation and the downregulation of NADPH oxidases NOX2 and NOX4. We also show that ectopic expression of α-cardiac actin protects HEK293 cells against oxidative stress induced by H 2 O 2 . Oxidative stress plays an important role in the development of c...